Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SciSparc Ltd. Regulatory Filings 2021

Feb 10, 2021

35501_ffr_2021-02-10_30cfb661-fbac-4ed2-b548-b8a67f0c596f.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

6-K 1 ea135124-6k_scisparcltd.htm REPORT OF FOREIGN PRIVATE ISSUER

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of February 2021 (Report No. 2)

Commission file number: 001- 38041

SCISPARC LTD.

(Translation of registrant’s name into English)

16 Abba Hillel Road

Ramat Gan 5250608, Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

CONTENTS

On February 10, 2021, SciSparc Ltd. (the “ Company ”) issued a press release titled: “SciSparc Engages Procaps for Development and Production of CannAmide™ and its SCI-110 Product Candidate.” A copy of this press release is furnished herewith as exhibit 99.1.

Field: Page; Sequence: 2; Options: NewSection; Value: 1

Field: Sequence; Type: Arabic; Name: PageNo 1 Field: /Sequence

Field: /Page

EXHIBIT INDEX

Exhibit No.
99.1 Press release titled: “SciSparc Engages Procaps for Development and Production of CannAmide™ and its SCI-110 Product Candidate.”

Field: Page; Sequence: 3; Value: 1

Field: Sequence; Type: Arabic; Name: PageNo 2 Field: /Sequence

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Oz Adler
Name: Oz Adler
Title: Chief Financial Officer

3

Field: Rule-Page

Field: /Rule-Page